For example, inhibition of apoptosis protease activating factor-1 (Apaf-1), a key regulatory enzyme of the apoptosis pathway, by a novel inhibitor (ZYZ-488) was found to have a protective effect on cardiomyocytes in cardiac ischemia [60]. This evidence concerns the gene APAF1 and myocardial ischemia.